XML 17 R6.htm IDEA: XBRL DOCUMENT v3.25.2
Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net (loss) income $ (14,763) $ (2,386)
Adjustments to reconcile net loss to net cash used in operating activities    
Depreciation and amortization 62 4
Share-based compensation expense 324 117
Accretion expense on convertible promissory note 126 0
Change in derivative fair value 9,369 0
Loss on settlement of convertible promissory note 1,353 0
Loss on shares issued for debt 217 0
Drawdown in shares issued for prepaid services 140 0
Shares issued for consulting services 32 0
Changes in operating assets and liabilities:    
Change in receivables (31) 1
Change in prepaid expenses (67) (35)
Change in inventory (37) 0
Change in trade payables (475) 810
Change in accrued liabilities (1,184) (929)
Change in deferred revenue 33 0
Net cash used in operating activities (4,901) (2,418)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Acquisition of new business, net of cash acquired (2,360)
Purchase of equipment (19) (64)
Product enhancement – intangible asset 0 (248)
Net cash used in investing activities (2,379) (312)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from sale of shares, net of issuance costs 2,560 945
Proceeds from exercise of warrants 8,828 0
Net cash provided by financing activities 11,388 945
INCREASE (DECREASE) IN CASH 4,108 (1,785)
BALANCE OF CASH AT THE BEGINNING OF PERIOD 1,810 2,143
BALANCE OF CASH AT THE END OF PERIOD 5,918 358
Supplemental cash flow information    
Cash paid for interest 0 0
Cash paid for income taxes 0 0
Non-cash investing and financing activities    
Shares issued for conversion of the convertible promissory note 426 0
Deemed dividend on warrant inducement (4,410) 0
Shares issued for debt 426 0
Non-cash acquisition of equipment 0 (60)
Evoke Neuroscience, Inc. [Member]    
Non-cash investing and financing activities    
Shares issued for Acquisition of new business 2,743 0
Conversion of Promissory Note to Common Stock [Member]    
Non-cash investing and financing activities    
Shares issued for conversion of the convertible promissory note 12,339 0
Shares issued for debt $ 12,339 $ 0